Our preclinical data of subcutaneous PCa model is consistent with clinical results showing that anti-PD-1 treatment alone can lead to increased CD8 + T cell infiltration and activation of positive immune molecules such as perforin but failed to affect PMN-MDSC infiltration significantly in the TME relative to placebo treatment. The gene discussed is CD8A; the disease is posterior cortical atrophy.